|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/54 | (2017.01) |
| A61K 47/542 | (2017.08) | ||
| A61K 47/55 | (2017.01) | ||
| A61K 47/55 | (2017.08) | ||
| A01N 37/18 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3075247 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15200535.1 |
| Date of filing the European patent application | 2005-02-02 | |
| (97) | Date of publication of the European application | 2016-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-12 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 540334 P | 2004-02-02 | US |
| (72) |
GENGRINOVITCH, Stela , IL
IZAKOVICH, Esther , IL
|
| (73) |
BioSight Ltd. ,
3 Hayarden Street
Airport City, P.O.Box 1083, Lod 7019802,
IL
|
| (54) | CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS |
| CONJUGATES FOR CANCER THERAPY AND DIAGNOSIS |